Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications: During stability testing an unknown impurity was found to be above the specification limit at 36 month test interval
| Brand name | QUINAPRIL |
| Generic name | QUINAPRIL |
| Active ingredient(s) | QUINAPRIL HYDROCHLORIDE |
| Distributed by / for | Lupin Pharmaceuticals, Inc., Baltimore, MD 21202 United States |
| NDC | 68180-556-09 |
| Full product label | Quinapril Tablets USP, 5 mg, 90 count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202 United States Manufactured by: Lupin Limited Goa 403 722 INDIA, NDC 68180-556-09 |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | Nationwide and Puerto Rico |
| Quantity | 30,264 bottles |
| Recall initiated | 2013-09-17 |
| Report date | 2014-01-22 |
| Recall completed | 2016-05-11 |
| Recall number | D-408-2014 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Baltimore MD United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗